The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant immuno-chemo-radiotherapy in operable esophageal and gastroesophageal junction adenocarcinoma with carboplatin, paclitaxel plus radiotherapy and avelumab (anti-PDL1 antibody): Neo-CREATE trial.
 
Amitesh Chandra Roy
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Ipsen; Merck Serono; MSD; Pierre Fabre; SERVIER
Consulting or Advisory Role - AstraZeneca; Medison; MSD
Research Funding - Merck KGaA
 
Tim F Bright
No Relationships to Disclose
 
Nimit Singhal
No Relationships to Disclose
 
Matthew E. Burge
Stock and Other Ownership Interests - coclear; CSL Limited; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Eva Segelov
No Relationships to Disclose
 
Andrew Mark Haydon
No Relationships to Disclose
 
Lorraine A. Chantrill
Honoraria - Amgen; Amgen; Eisai; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - BMS Australia; MSD Oncology
 
Michael Michael
Honoraria - Novartis; SAM NORDIC
Consulting or Advisory Role - Ipsen; Isotopen Technologien; MDS; Merck; PanTher Therapeutics
Research Funding - Ipsen
Travel, Accommodations, Expenses - Ipsen; Ipsen; Novartis
 
Caroline Connell
No Relationships to Disclose
 
David Moffat
No Relationships to Disclose
 
Richard John Woodman
No Relationships to Disclose
 
Michael Michael
No Relationships to Disclose
 
Erin Symonds
No Relationships to Disclose
 
Timothy Jay Price
Consulting or Advisory Role - Amgen; Astrazeneca (Inst); BMS (Inst); Merck; Takeda
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen
 
Alex Scott-Hoy
No Relationships to Disclose
 
Alison Richards
No Relationships to Disclose
 
Christos Stelios Karapetis
Honoraria - Eisai; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Lilly; Merck Serono; Pierre Fabre; Roche; Takeda